Apeiron and other key shareholders of atai life sciences reinforce support by entering into extended, voluntary share lock-up agreements

• apeiron and other key shareholders enter into voluntary lock-up agreements • this voluntary lock-up extends trading restrictions by 24 months for apeiron and 12 months for other investors • demonstrates strong ongoing confidence in atai's diversified platform and multiple innovative programs designed to address unmet patient need in mental health
ATAI Ratings Summary
ATAI Quant Ranking